Trials / Conditions / Gastrointestinal Carcinoid Tumor

Gastrointestinal Carcinoid Tumor

21 registered clinical trials studyying Gastrointestinal Carcinoid Tumor.

Status	Trial	Sponsor	Phase
Completed	Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblast NCT01048892	Children's Oncology Group	Phase 1
Terminated	Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Prim NCT00903396	Alliance for Clinical Trials in Oncology	Phase 2
Terminated	Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors NCT00730483	Yale University	N/A
Completed	AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors NCT00427349	Eastern Cooperative Oncology Group	Phase 2
Completed	Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer NCT00654160	Mayo Clinic	Phase 1
Unknown	Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroend NCT00454376	National Cancer Institute (NCI)	—
Completed	Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic N NCT00602082	Cambridge University Hospitals NHS Foundation Trust	Phase 2
Terminated	Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors NCT00227617	University of California, San Francisco	Phase 2 / Phase 3
Completed	Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroe NCT00416767	Federation Francophone de Cancerologie Digestive	Phase 2
Completed	Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors NCT00049023	O'Dorisio, M S	Phase 1
Completed	PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors NCT00017199	Ohio State University Comprehensive Cancer Center	Phase 2
Completed	Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors NCT00027638	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction NCT00004911	Northwestern University	Phase 1 / Phase 2
Completed	Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction NCT00004910	Northwestern University	Phase 1 / Phase 2
Completed	Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer NCT00003427	Memorial Sloan Kettering Cancer Center	Phase 1
Completed	Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestina NCT00019474	Montefiore Medical Center	Phase 2
Completed	Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer NCT00006368	Novartis Pharmaceuticals	Phase 1
Completed	Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Can NCT00005049	NYU Langone Health	Phase 2
Terminated	Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer NCT00002947	Yale University	Phase 1
Completed	Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors NCT00002470	Mid-Atlantic Oncology Program	Phase 2
Withdrawn	Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors NCT00227773	Eastern Cooperative Oncology Group	Phase 2